Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04834414 · ClinicalTrials.gov registry record · Phase 3
CHIlled Platelet Study "CHIPS"
A Phase 3 study of Acute Blood Loss, sponsored by Philip Spinella.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,000
- Enrollment target
- 20
- Study locations
NCT04834414 is a Phase 3 study of Acute Blood Loss that has completed, run by Philip Spinella. The registered enrollment target is 1,000 participants. The trial reports 20 study locations across 15 states.
The verdict
NCT04834414, a Phase 3 study of Acute Blood Loss, has completed, sponsored by Philip Spinella.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
A phase 3 randomized partial blind storage duration ranging study in patients undergoing complex cardiac surgery that will compare the transfusion of cold stored platelets to standard room temperature stored platelets. The primary objective is to establish that cold stored platelets have a non-inferiority (or superiority) to room temperature platelets.
Conditions Studied
Interventions
- BIOLOGICAL Cold Stored Platelets
- BIOLOGICAL Room Temperature Platelets
Study Locations (20)
Arizona
- Mayo Clinic Arizona - Phoenix
- Banner University Medical Center - Tucson
Illinois
- Northwestern Memorial Hospital - Chicago
- Loyola Universtiy Medical Center - Maywood
Minnesota
- University of Minnesota - Minneapolis
- Mayo Clinic - Rochester
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
- University of Pittsburgh Medical Center - Pittsburgh
Texas
- University of Texas Children's Medical Center - Dallas
- University of Texas Medical Center Clements - Dallas
California
- Ronald Reagan UCLA Medical Center - Los Angeles
Florida
- University of Florida - Gainesville
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2021-10-21 |
| Est. Completion | 2025-04-21 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04834414
The ClinicalTrials.gov registry entry for NCT04834414 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philip Spinella, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Blood Loss appearing as the primary indexed condition, and to 2 interventions - of which Cold Stored Platelets is the first listed.
NCT04834414 reports 20 study locations spanning 15 distinct geographic areas - top geographies include Arizona, Illinois, Minnesota.
Frequently Asked Questions
What is clinical trial NCT04834414 about?
NCT04834414 is a clinical study titled "CHIlled Platelet Study "CHIPS"". A phase 3 randomized partial blind storage duration ranging study in patients undergoing complex cardiac surgery that will compare the transfusion of cold stored platelets to standard room temperature stored platelets. The primary objective is to establish that cold stored platelets have a non-infer...
What is the current status of trial NCT04834414?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,000 participants. The study started on 2021-10-21. Estimated completion is 2025-04-21.
What conditions does trial NCT04834414 study?
This clinical trial studies the following conditions: Acute Blood Loss.
What interventions are being tested in trial NCT04834414?
The interventions under investigation include: Cold Stored Platelets (BIOLOGICAL), Room Temperature Platelets (BIOLOGICAL).
Who is sponsoring clinical trial NCT04834414?
This trial is sponsored by Philip Spinella, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04834414 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Illinois, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.